Výsledky vyhledávání - "Fred R. Rosen"

Biliary Tract Cancer in a Patient With a Virchow's Node

Autor: Yanting Wang, Fred R. Rosen, Rohit Agrawal

Publikováno v: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 18(11)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01e4443345f43e8e3d467029c283cefc
https://pubmed.ncbi.nlm.nih.gov/31629883

Zobrazit plný text záznamu

Impact of failure to thrive on inpatient mortality and resource utilization in patients with head and neck cancer: A nationwide analysis

Autor: Muhammad Zain Farooq, Prasanth Lingamaneni, Binav Baral, Ishaan Vohra, Trilok Shrivastava, Krishna Rekha Moturi, Fred R. Rosen

Publikováno v: Journal of Clinical Oncology. 38:e18531-e18531

e18531 Background: Failure to thrive (FTT), encompassing malnutrition and cachexia, is a common comorbidity afflicting Head and Neck cancer (HNC), brought about either by progression of disease or complications of treatment. FTT can exacerbate infect

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e2dc49aaed4da207b23dc08c2c82a8fa
https://doi.org/10.1200/jco.2020.38.15_suppl.e18531

Zobrazit plný text záznamu

HIV associated head and neck cancers in an inner-city minority population

Autor: Paul G. Rubinstein, Fred R. Rosen, Shweta Gupta, Tiago Araujo, Vatsala Katiyar

Publikováno v: Journal of Clinical Oncology. 37:e13124-e13124

e13124 Background: Head and Neck Cancer (HNC) is a common non-AIDS defining malignancy and its risk increases by 1.7 to 4-fold with HIV infection. Little is known about the epidemiology and outcomes in this subset of patients. This study was undertak

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9f09bec50e480794af2d7a0601902f75
https://doi.org/10.1200/jco.2019.37.15_suppl.e13124

Zobrazit plný text záznamu

Factors affecting adherence to standard cisplatin (CDDP)-based chemotherapy regimen for locally advanced squamous cell head and neck (H&N) cancer in an inner city safety net hospital

Autor: Fred R. Rosen, Pei Lu, Sunny R K Singh, Sindhu Janarthanam Malapati

Publikováno v: Journal of Clinical Oncology. 35:252-252

252 Background: The non-operative standard of care for advanced, non-metastatic H&N cancer is high dose CDDP (100 mg/m2) given every 21 days for 3 cycles concurrent with radiation. Many patients are either started on or switched to an alternative reg

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::680536079f3c69ed8ebcb7db5a85711e
https://doi.org/10.1200/jco.2017.35.31_suppl.252

Zobrazit plný text záznamu

Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer

Autor: Daniel J, Haraf, Fred R, Rosen, Kerstin, Stenson, Athanassios, Argiris, Bharat B, Mittal, Mary Ellyn, Witt, Bruce E, Brockstein, Marcy A, List, Louis, Portugal, Harold, Pelzer, Ralph R, Weichselbaum, Everett E, Vokes

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 9(16 Pt 1)

Induction chemotherapy with carboplatin and paclitaxel followed by concomitant TFHX (paclitaxel, infusional 5-fluorouracil, hydroxyurea, and twice-daily radiation therapy administered every other week) has resulted in 70% 3-year survival in stage IV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6940700042bf9eb9e6c5446b5f7b89fb
https://pubmed.ncbi.nlm.nih.gov/14676118

Zobrazit plný text záznamu

P-0087 Safety and Tolerability of Sorafenib in Child-Pugh B Patients with Hepatocellular Carcinoma: a Single Center Experience

Autor: Barbara Yim, Fred R. Rosen, Shweta Gupta, Sumedha Dhar

Publikováno v: Annals of Oncology. 23:iv56-iv57

Introduction Sorafenib is a Tyrosine Kinase Inhibitor approved for the treatment of advanced hepatocellular cancer (HCC). The phase III trial, which led to the approval of sorafenib accrued most patients with Child-Pugh score of A. There is very litt

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::11ad528536fbedbd57ef49467c180f63
https://doi.org/10.1016/s0923-7534(20)30294-5

Zobrazit plný text záznamu

A retrospective analysis of all non-AIDS defining cancers (NADC): A subset analysis of the County Hospital AIDS Malignancy Project (CHAMP)

Autor: Audrey L. French, Prantesh Jain, Paul G. Rubinstein, Shweta Gupta, Emilio Araujo Mino, Fred R. Rosen

Publikováno v: Journal of Clinical Oncology. 30:1611-1611

1611 Background: County Hospital (CCH) with its HIV clinic, the CORE Center (CC) is the largest provider for HIV patients (pts) in Chicago, treating over 5,500 HIV pts yearly. There is paucity of data on characteristics of HIV+ cancers (ca) in the in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fac9db7f746de3ee895ec3e4166eb097
https://doi.org/10.1200/jco.2012.30.15_suppl.1611

Zobrazit plný text záznamu

Cetuximab-induced thrombotic thrombocytopenic purpura in a patient with a resected squamous cell carcinoma of the lip

Autor: M. Yogore, Sunita Nathan, Barbara Yim, Margaret Clare Telfer, Decebal S. Griza, Ahmad Jajeh, Fred R. Rosen, Rose Catchatourian, Thomas E. Lad, Samuel Ofori-Ntow

Publikováno v: Journal of Clinical Oncology. 25:14155-14155

14155 Background: Chemotherapy-associated thrombotic thrombocytopenic purpura (TTP) has been described in the literature. However Cetuximab, a monoclonal antibody targeted to the EGF receptor, has not yet been associated with TTP. We report a case of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::37ea36897e880d233b23c8ed13ac0683
https://doi.org/10.1200/jco.2007.25.18_suppl.14155

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání